Terms: = Sarcomas AND PDCD1, CD279, PD-1, PD1, SLEB2, hPD-1, hPD-l, hSLE1 AND Prognosis
87 results:
1. Radiotherapy combined with anti-pd-1 and TKI for primary cardiac angiosarcoma considering the joint assessment of TLSs and PD-L1: a case report.
Deng S; Yang X; He L; Zhang Q; Zhao C; Meng H
J Cardiothorac Surg; 2024 Apr; 19(1):194. PubMed ID: 38594687
[TBL] [Abstract] [Full Text] [Related]
2. Evaluation of the efficacy and safety of immunotherapy in sarcoma: a two-center study.
Liao Z; Teng J; Li T; Liu H; Li T; Zhang C; Xing R; Teng S; Yang Y; Zhao J; Xiao W; Zhang G; Li MJ; Yao W; Yang J
Front Immunol; 2024; 15():1292325. PubMed ID: 38585276
[TBL] [Abstract] [Full Text] [Related]
3. The Development and Characterization of a Next-Generation Oncolytic Virus Armed with an Anti-pd-1 sdAb for Osteosarcoma Treatment
Higgins TA; Patton DJ; Shimko-Lofano IM; Eller TL; Molinari R; Sandey M; Ismail A; Smith BF; Agarwal P
Cells; 2024 Feb; 13(4):. PubMed ID: 38391964
[TBL] [Abstract] [Full Text] [Related]
4. Unraveling T cell exhaustion in the immune microenvironment of osteosarcoma via single-cell RNA transcriptome.
Cheng D; Zhang Z; Liu D; Mi Z; Tao W; Fu J; Fan H
Cancer Immunol Immunother; 2024 Jan; 73(2):35. PubMed ID: 38280005
[TBL] [Abstract] [Full Text] [Related]
5. Clinical and therapeutical significances of the cluster and signature based on oxidative stress for osteosarcoma.
Ding M; Ran X; Qian S; Zhang Y; Wang Z; Dong M; Yang Z; Wu S; Feng X; Zhang J; Zhu L; Niu S; Zhang X
Aging (Albany NY); 2023 Dec; 15(24):15360-15381. PubMed ID: 38180104
[TBL] [Abstract] [Full Text] [Related]
6. Identification and verification of PTPN3 as a novel biomarker in predicting cancer prognosis, immunity, and immunotherapeutic efficacy.
Zhou Z; Lin Z; Wang M; Wang L; Ji Y; Yang J; Yang Y; Zhu G; Liu T
Eur J Med Res; 2024 Jan; 29(1):12. PubMed ID: 38173048
[TBL] [Abstract] [Full Text] [Related]
7. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
8. Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker.
Xu Y; Lin Z; Ji Y; Zhang C; Tang X; Li C; Liu T
Eur J Med Res; 2023 Oct; 28(1):438. PubMed ID: 37848933
[TBL] [Abstract] [Full Text] [Related]
9. Inhibitory checkpoint molecule mRNA expression in canine soft tissue sarcoma.
Stevenson VB; Gudenschwager-Basso EK; Klahn S; LeRoith T; Huckle WR
Vet Comp Oncol; 2023 Dec; 21(4):709-716. PubMed ID: 37680007
[TBL] [Abstract] [Full Text] [Related]
10. Diagnosis and management of gastrointestinal SMARCA4-deficient undifferentiated tumors.
Wang J; Elghawy O; Kurpiel B; Kaur V
Clin J Gastroenterol; 2023 Dec; 16(6):807-814. PubMed ID: 37651059
[TBL] [Abstract] [Full Text] [Related]
11. A novel stratification framework based on anoikis-related genes for predicting the prognosis in patients with osteosarcoma.
Zhang X; Wen Z; Wang Q; Ren L; Zhao S
Front Immunol; 2023; 14():1199869. PubMed ID: 37575253
[TBL] [Abstract] [Full Text] [Related]
12. Pembrolizumab for the adjuvant treatment of IIB or IIC melanoma.
Rutkowski P; Czarnecka AM
Expert Rev Anticancer Ther; 2023; 23(9):897-902. PubMed ID: 37573515
[TBL] [Abstract] [Full Text] [Related]
13. Sintilimab plus bevacizumab and CapeOx (BBCAPX) on first-line treatment in patients with RAS mutant, microsatellite stable, metastatic colorectal cancer: study protocol of a randomized, open-label, multicentric study.
Fang X; Zhong C; Weng S; Hu H; Wang J; Xiao Q; Wang J; Sun L; Xu D; Liao X; Dong C; Zhang S; Li J; Ding K; Yuan Y
BMC Cancer; 2023 Jul; 23(1):676. PubMed ID: 37464378
[TBL] [Abstract] [Full Text] [Related]
14. Osteosarcoma-Associated Immune Genes as Potential Immunotherapy and prognosis Biomarkers.
Yang L; Long Y; Xiao S
Biochem Genet; 2024 Apr; 62(2):798-813. PubMed ID: 37452172
[TBL] [Abstract] [Full Text] [Related]
15. Diagnostic Challenges in pd-1 Inhibitor Induced Panuveitis in a Teenage Girl with Chest Soft Tissue Sarcoma - A Case Report.
Shen Y; Gong Y; Su L
Ocul Immunol Inflamm; 2023 Dec; 31(10):2065-2068. PubMed ID: 37442377
[TBL] [Abstract] [Full Text] [Related]
16. Ferroptosis-related gene HIC1 in the prediction of the prognosis and immunotherapeutic efficacy with immunological activity.
Wu Y; Lin Z; Tang X; Tong Z; Ji Y; Xu Y; Zhou Z; Yang J; Li Z; Liu T
Front Immunol; 2023; 14():1182030. PubMed ID: 37388742
[TBL] [Abstract] [Full Text] [Related]
17. Next generation sequencing predicting clinical effect of immunotherapy on adult rhabdomyosarcoma patient: A case report.
Sun X; Wang X; Zhou J; Xu Y; Zhang H; Xu M; Shen J; Shi X; Song W; Li J
Medicine (Baltimore); 2023 May; 102(21):e33858. PubMed ID: 37233406
[TBL] [Abstract] [Full Text] [Related]
18. Pathological characteristics and immune microenvironment of SMARCA4-deficient undifferentiated uterine sarcoma.
Gao J; Fan R; Chen D; Hou J; Chen H; Lu M
Diagn Pathol; 2023 May; 18(1):62. PubMed ID: 37194064
[TBL] [Abstract] [Full Text] [Related]
19. Genomic Profiling of Radiation-Induced sarcomas Reveals the Immunologic Characteristics and Its Response to Immune Checkpoint Blockade.
Hong DC; Yang J; Sun C; Liu YT; Shen LJ; Xu BS; Que Y; Xia X; Zhang X
Clin Cancer Res; 2023 Aug; 29(15):2869-2884. PubMed ID: 37184976
[TBL] [Abstract] [Full Text] [Related]
20. Anaplastic Classic Kaposi Sarcoma: PD-L1 Expression and Response to Immunotherapy: A Case Report and Review of the Literature.
Lolli I; Valentini AM; Ricci AD; Armentano R
J Natl Compr Canc Netw; 2023 Apr; 21(5):442-448.e2. PubMed ID: 37028800
[TBL] [Abstract] [Full Text] [Related]
[Next]
